Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

NHS England

This public procurement record has 1 release in its history.

Award

29 Jul 2025 at 15:36

Award Notice
Summary of the contracting process

NHS England has completed a procurement process for a framework agreement titled "NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025" aimed at supplying pharmaceutical products. The industries involved are pharmaceutical, with a total value of £4,108,145,000. The tender, classified under CPV code 33600000, encompasses areas in the United Kingdom, Channel Islands, and others, with the contract period commencing on 1 September 2025 and ending on 31 August 2027. The procurement stage is currently at the 'Award' phase as of 29 July 2025. The open procedure was above the threshold and was designed to include SMEs in the bidding process. This process also details the framework agreement's flexibility to extend for additional periods, indicating a robust and long-term supply opportunity.

This tender presents a significant opportunity for firms in the pharmaceutical industry to engage with NHS England, a key player and buyer in the healthcare sector. With a focus on both large suppliers and SMEs, the framework agreement provides multiple chances for participation across a broad geographical scope. Companies such as Biogen and Amgen Ltd, which have been successful suppliers, illustrate the competitive landscape. This framework is particularly suitable for businesses providing branded medicines, offering a substantial business growth opportunity through long-term collaboration with a national health service. Active involvement can yield benefits from a stable and assured market for the duration of the contract and potential extensions.

How relevant is this notice?

Notice Information

Notice Title

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

Notice Description

NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/cc644418-f584-45db-bf35-771baf03bc48
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£4,108,145,000 £1B-£10B
Lots Value
Not specified
Awards Value
£986,282,758 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
29 Jul 20251 years ago
Submission Deadline
7 Apr 2025Expired
Future Notice Date
Not specified
Award Date
1 Jul 20251 years ago
Contract Period
1 Sep 2025 - 31 Aug 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
Not specified
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
21
Supplier Names

Biogen Idec Limited

Amgen Ltd

Swedish Orphan Biovitrum Ltd

Zentiva Pharma UK Ltd

Fresenius Kabi Limited

Sandoz Ltd

THORNTON & ROSS LIMITED

Roche Products Ltd

Accord-UK Ltd

GlaxoSmithKline UK Limited

Samsung Bioepis UK Ltd

Pfizer Ltd

Janssen-Cilag Ltd

Celltrion Healthcare

Abbvie Ltd

Takeda UK Limited

Organon Pharmaceuticals UK Ltd

Alexion Pharmaceuticals

Orifarm UK Ltd

CuraTeQ Biologics s.r.o.

Dr.Reddy's Laboratories (UK) Limited

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...